EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131

Jennifer R Eads, Ju-Whei Lee, Cheng E Chee, Neal J Meropol, Al B Benson, Paul Catalano, Efrat Dotan, Dana B Cardin, Peter J O'Dwyer

Clinical Colorectal Cancer · 2026-09

DOI: 10.1016/j.clcc.2026.08.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Colorectal Cancer, 2026-09. Verfasst von Jennifer R Eads und 8 weiteren Autor:innen. Beteiligte Einrichtung: Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. Electronic address: jennifer.eads@pennmedicine.upenn.edu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cell cycle checkpoint inhibitionClinical trialPancreatic cancerToxicityWee1

Autor:innen und Institutionen

  • Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA. Electronic address: jennifer.eads@pennmedicine.upenn.edu.
  • Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • National University Cancer Institute Singapore, National University Health System, Singapore, Singapore.
  • Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH; Neal Meropol, LLC, New York, NY.
  • Northwestern University, Division of Hematology and Oncology, Chicago, IL.
  • Fox Chase Cancer Center, Division of Hematology and Oncology, Philadelphia, PA; Penn Medicine, Ann B. Barshinger Cancer Center, Lancaster General Health, Lancaster, PA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Eads, J. R., Lee, J. W., Chee, C. E., Meropol, N. J., Benson, A. B., Catalano, P., Dotan, E., Cardin, D. B., & O'Dwyer, P. J. (2026). A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2026.08.004

Vancouver

Eads JR, Lee JW, Chee CE, Meropol NJ, Benson AB, Catalano P, et al. A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131. Clinical Colorectal Cancer. 2026. doi:10.1016/j.clcc.2026.08.004

BibTeX
@article{Eads2026,
  author = {Eads, Jennifer R and Lee, Ju-Whei and Chee, Cheng E and Meropol, Neal J and Benson, Al B and Catalano, Paul and Dotan, Efrat and Cardin, Dana B and O'Dwyer, Peter J},
  title = {A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA2131},
  journal = {Clinical Colorectal Cancer},
  year = {2026},
  doi = {10.1016/j.clcc.2026.08.004}
}
Kostenlos starten →